SCHIMMEL PAUL purchased 14.7% of their position (100K shares) of ATYR PHARMA INC on the open market
Open‑market purchase worth $49.6K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/28/2026ACC: 0001236447-26-000006
+100K
Net shares
Net buyer
$49.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+100K
Price / share
$0.50
Trade value
$49.63K
% of position
14.7%
5/27/2026
679.14K→779.14K
Total
Net shares
+100K
Net value
$49.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/27/2026 | P · Purchase | +100K | $0.50 | $49.63K | 14.7% | 679.14K | 779.14K |
| Total | +100K | $49.63K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.41M
Common Stock
DirectShares owned8.89K
Total
8.89K direct·1.41M indirect1.42M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.41M | Indirect |
| Common Stock | 8.89K | Direct |
| Total | 1.42M | 8.89K direct·1.41M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported